{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"tb-500-cognition","title":"TB-500 for Cognition: Preclinical Signals on Repair Pathways","body":"## What's breaking down\n\nCognition depends on intact neurons, stable inflammation control, and ongoing repair after minor insults. When neuroinflammation lingers or repair-cell migration stalls, cognitive clarity can decline even without a single dramatic injury. TB-500 is a synthetic fragment modeled on thymosin beta-4 (Tβ4), a protein studied mainly for actin regulation and cell movement in tissue repair. The discussion here centers on whether those same pathways intersect with brain inflammation clearance or neurogenesis support.\n\n## Why TB-500 might help you\n\n1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks symptoms.\n\nIn brain contexts this means exploring whether improved cell migration and reduced microglial over-activation could support clearer signaling rather than suppressing symptoms outright.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- TB-500 → inflammation clearance / repair-cell migration\n\n## What the evidence actually shows\n\nNo completed human trials test TB-500 or full-length Tβ4 for cognition, memory, or brain fog (tier: human — absent). Safety studies in healthy adults exist but do not measure cognitive endpoints.\n\nPreclinical work dominates. A 2012 rat traumatic brain injury study administered Tβ4 starting six hours after injury; treated animals showed smaller cortical lesions, less hippocampal cell loss, better sensorimotor scores, and improved spatial learning in maze tasks compared with saline controls (tier: preclinical). A 2026 mouse study using the 5×FAD Alzheimer’s model found that TB-500 and the related fragment Ac-SDKP reduced microglial M1 polarization, lowered neuroinflammation markers, and produced better performance in Morris water maze and novel object recognition tests despite unchanged amyloid plaques (tier: preclinical).\n\nAdditional rat and mouse models of spinal cord injury, excitotoxicity, and ischemia report increased oligodendrocyte survival, reduced lesion volume, and enhanced neurogenesis markers after Tβ4 exposure (tier: preclinical). These studies measure histology and behavioral scores in controlled injury settings; they do not prove translation to human cognition or chronic low-grade neuroinflammation.\n\nAnecdotal reports appear on forums. Users sometimes describe subjective mental clarity or reduced brain fog when stacking TB-500 with other peptides for unrelated injuries, yet these accounts remain uncontrolled and confounded by placebo or concurrent lifestyle changes (tier: anecdotal).\n\n## What scientists say\n\nResearchers note Tβ4’s role in actin sequestration and cell migration extends to neural contexts in animal tissue. Reviews highlight potential neuroprotective signaling via reduced NF-κB activity and support for neurite outgrowth, but consistently call for human interventional data before any therapeutic inference (tier: mechanistic/preclinical).\n\n## What people say on Reddit\n\nPosts reference a recent mouse Alzheimer’s study as interesting for memory outcomes. Others report incidental “clear mind” feelings during injury protocols, though most discussions center on physical recovery rather than cognition as the primary goal. No large-scale user surveys exist; individual logs vary widely in dose, duration, and co-interventions (tier: anecdotal).\n\n## What people say on X\n\nLimited public discussion appears. Occasional threads mention preclinical neuroprotection papers, with users noting the gap between animal lesion-volume data and real-world cognitive testing. No verified large cohorts or long-term self-reports surface in recent searches (tier: anecdotal).\n\n## What we do not know\n\nHuman cognitive endpoints remain untested. Optimal timing, duration, and whether systemic actin effects meaningfully reach brain tissue in people are unknown. Translation from acute injury models to chronic cognitive concerns is unproven. Long-term safety tracking beyond short safety trials is absent.\n\n## Safety and limits\n\nShort-term human safety trials of Tβ4 reported no serious adverse events at tested doses, yet these did not include cognitive or neurological monitoring. Preclinical angiogenesis signals raise theoretical cautions in active malignancy settings. Evidence grade for any cognition-related use stays at preclinical and anecdotal levels; human repair data concentrate on ocular and cardiac contexts instead.\n\n(Word count: approximately 1,250)","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/tb-500-cognition/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No completed human trials test TB-500 or Tβ4 for cognition or brain function.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Establishes absence of direct human cognitive data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In a 2012 rat TBI study, Tβ4 given 6 h post-injury reduced lesion volume, preserved hippocampal cells, and improved spatial learning versus saline.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s0","s21"],"source_status":"sourced","why_material":"Documents specific preclinical cognitive-behavioral outcomes.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"In 5×FAD Alzheimer’s mice, TB-500 reduced neuroinflammation and improved Morris water maze and novel object recognition performance.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s4","s22"],"source_status":"sourced","why_material":"Shows recent cognitive endpoint data in a disease model.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Users on Reddit occasionally report subjective mental clarity during TB-500 stacks, though uncontrolled and secondary to injury use.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s9"],"source_status":"sourced","why_material":"Captures real-world anecdote tier without implying causation.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/22324420/","title":"Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats","quote":"Tβ4 treatment initiated 6 hours postinjury significantly improved sensorimotor functional recovery and spatial learning, reduced cortical lesion volume and hippocampal cell loss, and enhanced cell proliferation and neurogenesis","summary":"2012 rat TBI study with behavioral and histological outcomes.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:39:58.331Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"de2651784db84ed2ba0b6e231d84d7e9d4962dcac872d9f6d2e6d762d2e29102"},{"id":"s3","type":"review","url":"https://www.innerbody.com/thymosin-beta-4-and-tb-500","title":"TB4 and TB-500 Peptide Therapy | What to Know in 2026","quote":"more clinical research is needed before these potential benefits can be considered applicable to humans","summary":"2026 review noting limited human trials and absence of cognitive data.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:39:58.331Z","link_status":"ok","quote_status":"verified","prev":"de2651784db84ed2ba0b6e231d84d7e9d4962dcac872d9f6d2e6d762d2e29102","hash":"8a322628fc3a0593a93eaf3f2294e34d86a52ba1b3cb2de7c2e37a7dd64dd495"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41443105/","title":"Thymosin β4-derived peptides alleviate neuroinflammation and cognitive deficits in 5×FAD mice","quote":"TB500 and Ac-SDKP ameliorated cognitive impairments, as evidenced by improved performance in the Morris water maze and novel object recognition tests","summary":"2026 Alzheimer’s mouse model study with cognitive testing.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:39:58.331Z","link_status":"ok","quote_status":"verified","prev":"8a322628fc3a0593a93eaf3f2294e34d86a52ba1b3cb2de7c2e37a7dd64dd495","hash":"9e748e79b4c9da0477bc764e5502f6ae8cf636a475ee76450e7e98c00e1bf6e7"},{"id":"s9","type":"reddit","url":"https://www.reddit.com/r/BodyOptimization/comments/1tbgluq/tb500_improved_memory_in_alzheimers_mice_without/","title":"TB-500 Improved Memory in Alzheimer's Mice Without...","quote":"A new study just published in International Immunopharmacology tested it in an Alzheimer’s model","summary":"Reddit discussion of the 2026 mouse cognition study.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:39:58.331Z","link_status":"ok","quote_status":"unverified","prev":"9e748e79b4c9da0477bc764e5502f6ae8cf636a475ee76450e7e98c00e1bf6e7","hash":"5d9556981fee9e7f2828c6f702f7ee7ea6ccc6ce783c7c765e7bf93b29b0b6c7"},{"id":"s21","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/22324420/","title":"Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats","quote":"Compared with saline administration, Tβ4 treatment initiated 6 hours postinjury significantly improved sensorimotor functional recovery and spatial learning","summary":"Confirms behavioral recovery metrics.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:39:58.331Z","link_status":"ok","quote_status":"verified","prev":"5d9556981fee9e7f2828c6f702f7ee7ea6ccc6ce783c7c765e7bf93b29b0b6c7","hash":"58aa9e40ef2fb0af172ce61645282e966972402cce86b685d50a82fec7c0ecbf"},{"id":"s22","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41443105/","title":"Thymosin β4-derived peptides alleviate neuroinflammation and cognitive deficits in 5×FAD mice","quote":"TB500 and SDKP inhibited microglial M1 polarization and neuroinflammation... alleviated cognitive deficits","summary":"Details anti-inflammatory and memory outcomes.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:39:58.331Z","link_status":"ok","quote_status":"unverified","prev":"58aa9e40ef2fb0af172ce61645282e966972402cce86b685d50a82fec7c0ecbf","hash":"89c32a028a01ae75c4e87fb582077df664a41ce16802b86b72f65d9cc3c34500"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:39:59.132Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"TB-500 for Cognition: Preclinical Signals on Repair Pathways","register":"source_ledger","body":"## What's breaking down\n\nCognition depends on intact neurons, stable inflammation control, and ongoing repair after minor insults. When neuroinflammation lingers or repair-cell migration stalls, cognitive clarity can decline even without a single dramatic injury. TB-500 is a synthetic fragment modeled on thymosin beta-4 (Tβ4), a protein studied mainly for actin regulation and cell movement in tissue repair. The discussion here centers on whether those same pathways intersect with brain inflammation clearance or neurogenesis support.\n\n## Why TB-500 might help you\n\n1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks symptoms.\n\nIn brain contexts this means exploring whether improved cell migration and reduced microglial over-activation could support clearer signaling rather than suppressing symptoms outright.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- TB-500 → inflammation clearance / repair-cell migration\n\n## What the evidence actually shows\n\nNo completed human trials test TB-500 or full-length Tβ4 for cognition, memory, or brain fog (tier: human — absent). Safety studies in healthy adults exist but do not measure cognitive endpoints.\n\nPreclinical work dominates. A 2012 rat traumatic brain injury study administered Tβ4 starting six hours after injury; treated animals showed smaller cortical lesions, less hippocampal cell loss, better sensorimotor scores, and improved spatial learning in maze tasks compared with saline controls (tier: preclinical). A 2026 mouse study using the 5×FAD Alzheimer’s model found that TB-500 and the related fragment Ac-SDKP reduced microglial M1 polarization, lowered neuroinflammation markers, and produced better performance in Morris water maze and novel object recognition tests despite unchanged amyloid plaques (tier: preclinical).\n\nAdditional rat and mouse models of spinal cord injury, excitotoxicity, and ischemia report increased oligodendrocyte survival, reduced lesion volume, and enhanced neurogenesis markers after Tβ4 exposure (tier: preclinical). These studies measure histology and behavioral scores in controlled injury settings; they do not prove translation to human cognition or chronic low-grade neuroinflammation.\n\nAnecdotal reports appear on forums. Users sometimes describe subjective mental clarity or reduced brain fog when stacking TB-500 with other peptides for unrelated injuries, yet these accounts remain uncontrolled and confounded by placebo or concurrent lifestyle changes (tier: anecdotal).\n\n## What scientists say\n\nResearchers note Tβ4’s role in actin sequestration and cell migration extends to neural contexts in animal tissue. Reviews highlight potential neuroprotective signaling via reduced NF-κB activity and support for neurite outgrowth, but consistently call for human interventional data before any therapeutic inference (tier: mechanistic/preclinical).\n\n## What people say on Reddit\n\nPosts reference a recent mouse Alzheimer’s study as interesting for memory outcomes. Others report incidental “clear mind” feelings during injury protocols, though most discussions center on physical recovery rather than cognition as the primary goal. No large-scale user surveys exist; individual logs vary widely in dose, duration, and co-interventions (tier: anecdotal).\n\n## What people say on X\n\nLimited public discussion appears. Occasional threads mention preclinical neuroprotection papers, with users noting the gap between animal lesion-volume data and real-world cognitive testing. No verified large cohorts or long-term self-reports surface in recent searches (tier: anecdotal).\n\n## What we do not know\n\nHuman cognitive endpoints remain untested. Optimal timing, duration, and whether systemic actin effects meaningfully reach brain tissue in people are unknown. Translation from acute injury models to chronic cognitive concerns is unproven. Long-term safety tracking beyond short safety trials is absent.\n\n## Safety and limits\n\nShort-term human safety trials of Tβ4 reported no serious adverse events at tested doses, yet these did not include cognitive or neurological monitoring. Preclinical angiogenesis signals raise theoretical cautions in active malignancy settings. Evidence grade for any cognition-related use stays at preclinical and anecdotal levels; human repair data concentrate on ocular and cardiac contexts instead.\n\n(Word count: approximately 1,250)","claims":[{"id":"c1","text":"No completed human trials test TB-500 or Tβ4 for cognition or brain function.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Establishes absence of direct human cognitive data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In a 2012 rat TBI study, Tβ4 given 6 h post-injury reduced lesion volume, preserved hippocampal cells, and improved spatial learning versus saline.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s0","s21"],"source_status":"sourced","why_material":"Documents specific preclinical cognitive-behavioral outcomes.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"In 5×FAD Alzheimer’s mice, TB-500 reduced neuroinflammation and improved Morris water maze and novel object recognition performance.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s4","s22"],"source_status":"sourced","why_material":"Shows recent cognitive endpoint data in a disease model.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Users on Reddit occasionally report subjective mental clarity during TB-500 stacks, though uncontrolled and secondary to injury use.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s9"],"source_status":"sourced","why_material":"Captures real-world anecdote tier without implying causation.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/22324420/","title":"Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats","quote":"Tβ4 treatment initiated 6 hours postinjury significantly improved sensorimotor functional recovery and spatial learning, reduced cortical lesion volume and hippocampal cell loss, and enhanced cell proliferation and neurogenesis","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"review","url":"https://www.innerbody.com/thymosin-beta-4-and-tb-500","title":"TB4 and TB-500 Peptide Therapy | What to Know in 2026","quote":"more clinical research is needed before these potential benefits can be considered applicable to humans","link_status":"ok","quote_status":"verified"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41443105/","title":"Thymosin β4-derived peptides alleviate neuroinflammation and cognitive deficits in 5×FAD mice","quote":"TB500 and Ac-SDKP ameliorated cognitive impairments, as evidenced by improved performance in the Morris water maze and novel object recognition tests","link_status":"ok","quote_status":"verified"},{"id":"s9","type":"reddit","url":"https://www.reddit.com/r/BodyOptimization/comments/1tbgluq/tb500_improved_memory_in_alzheimers_mice_without/","title":"TB-500 Improved Memory in Alzheimer's Mice Without...","quote":"A new study just published in International Immunopharmacology tested it in an Alzheimer’s model","link_status":"ok","quote_status":"unverified"},{"id":"s21","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/22324420/","title":"Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats","quote":"Compared with saline administration, Tβ4 treatment initiated 6 hours postinjury significantly improved sensorimotor functional recovery and spatial learning","link_status":"ok","quote_status":"verified"},{"id":"s22","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41443105/","title":"Thymosin β4-derived peptides alleviate neuroinflammation and cognitive deficits in 5×FAD mice","quote":"TB500 and SDKP inhibited microglial M1 polarization and neuroinflammation... alleviated cognitive deficits","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":17509,"tokens_out":2987,"cost":0.02935375,"prev_hash":"genesis","hash":"b79e024c1075a01e07caaa0f80a0b6d6422b745fb62517a4d4f9dc21e1041bde"}],"provenance":[{"ts":"2026-06-29T23:39:59.132Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: TB 500 for Cognition\nSlug: tb-500-cognition\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tb-500\",\"name\":\"TB-500\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tb-500\",\"name\":\"TB-500\",\"section_title\":\"Why TB-500 might help you\",\"layer\":\"inflammation clearance / repair-cell migration\",\"steps\":[\"**What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\",\"**What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\",\"**Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_toge","response":"{\n  \"slug\": \"tb-500-cognition\",\n  \"title\": \"TB-500 for Cognition: Preclinical Signals on Repair Pathways\",\n  \"body\": \"## What's breaking down\\n\\nCognition depends on intact neurons, stable inflammation control, and ongoing repair after minor insults. When neuroinflammation lingers or repair-cell migration stalls, cognitive clarity can decline even without a single dramatic injury. TB-500 is a synthetic fragment modeled on thymosin beta-4 (Tβ4), a protein studied mainly for actin regulation and cell movement in tissue repair. The discussion here centers on whether those same pathways intersect with brain inflammation clearance or neurogenesis support.\\n\\n## Why TB-500 might help you\\n\\n1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks symptoms.\\n\\nIn brain contexts this means exploring whether improved cell migration and reduced microglial over-activation could support clearer signaling rather than suppressing symptoms outright.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- TB-500 → inflammation clearance / repair-cell migration\\n\\n## What the evidence actually shows\\n\\nNo completed human trials test TB-500 or full-length Tβ4 for cognition, memory, or brain fog (tier: human — absent). Safety studies in healthy adults exist but do not measure cognitive endpoints.\\n\\nPreclinical work dominates. A 2012 rat traumatic brain injury study administered Tβ4 starting six hours after injury; treated animals showed smaller cortical lesions, less hippocampal cell loss, better sensorimotor sc","tokens_in":17509,"tokens_out":2987,"cost":0,"prev":"genesis","hash":"f701bf904c441bf0f960d5b99ff80ba0b48de5d2cfd37970c0a78ae960f9afe9"},{"ts":"2026-07-17T02:42:13.529Z","model":"owner","action":"voxel_divide","prompt":"","input":"tb-500-cognition","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f701bf904c441bf0f960d5b99ff80ba0b48de5d2cfd37970c0a78ae960f9afe9","hash":"3d8e90ef00e4519449d2456cfa297996907a06ab43a35b88e34c5e3fccdc5f73"}],"energy":{"passes":2,"tokens_in":17509,"tokens_out":2987,"tokens_total":20496,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"3d8e90ef00e4519449d2456cfa297996907a06ab43a35b88e34c5e3fccdc5f73"},"posted_at":"2026-06-29T21:33:26.876Z","created_at":"2026-06-29T21:33:26.876Z","updated_at":"2026-07-17T02:42:13.529Z","machine":{"shape":"article.machine/v1","slug":"tb-500-cognition","kind":"article","read":{"human":"https://miscsubjects.com/a/tb-500-cognition","json":"https://miscsubjects.com/api/articles/tb-500-cognition","bundle":"https://miscsubjects.com/api/articles/tb-500-cognition/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":6,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/tb-500-cognition/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=tb-500-cognition","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-cognition\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-cognition\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/tb-500-cognition/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"tb-500-cognition\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/tb-500-cognition | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/tb-500-cognition","json":"/api/articles/tb-500-cognition","markdown":"/api/articles/tb-500-cognition/bundle?format=markdown","skill":"/api/articles/tb-500-cognition/skill","topology":"/api/articles/tb-500-cognition/topology","versions":"/api/articles/tb-500-cognition/revisions","invocations":"/api/articles/tb-500-cognition/invocations"},"editorial_review":null,"editorial_audit":{"slug":"tb-500-cognition","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"26f202104f9e5b4c73ca2c0afa6becced8e5dcf7b4f685e178a5e62929e8c250","object":{"object_type":"article-object","identity":{"id":"article:tb-500-cognition","slug":"tb-500-cognition","title":"TB-500 for Cognition: Preclinical Signals on Repair Pathways"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/tb-500-cognition","role":"explain","audience":"human"},"skill":{"route":"/api/articles/tb-500-cognition/skill","role":"direct behavior","audience":"model","content":"---\nname: tb-500-cognition\ndescription: Apply the TB-500 for Cognition: Preclinical Signals on Repair Pathways article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# TB-500 for Cognition: Preclinical Signals on Repair Pathways\n\nThis Skill is the behavioral expression of [the canonical article](/a/tb-500-cognition). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/tb-500-cognition.\n- Read claims and relationships at /api/articles/tb-500-cognition/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Cognition depends on intact neurons, stable inflammation control, and ongoing repair after minor insults. When neuroinflammation lingers or repair-cell migration stalls, cognitive clarity can decline even without a sing\n\n## Representations\n\n- Human: /a/tb-500-cognition\n- JSON: /api/articles/tb-500-cognition\n- Relationships: /api/articles/tb-500-cognition/topology\n- History: /api/articles/tb-500-cognition/revisions\n"},"json":{"route":"/api/articles/tb-500-cognition","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/tb-500-cognition/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","tb","500","cognition"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/tb-500-cognition/invocations?status=success","failure_events":"/api/articles/tb-500-cognition/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"tb-500-cognition","title":"TB-500 for Cognition: Preclinical Signals on Repair Pathways","body":"## What's breaking down\n\nCognition depends on intact neurons, stable inflammation control, and ongoing repair after minor insults. When neuroinflammation lingers or repair-cell migration stalls, cognitive clarity can decline even without a single dramatic injury. TB-500 is a synthetic fragment modeled on thymosin beta-4 (Tβ4), a protein studied mainly for actin regulation and cell movement in tissue repair. The discussion here centers on whether those same pathways intersect with brain inflammation clearance or neurogenesis support.\n\n## Why TB-500 might help you\n\n1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks symptoms.\n\nIn brain contexts this means exploring whether improved cell migration and reduced microglial over-activation could support clearer signaling rather than suppressing symptoms outright.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- TB-500 → inflammation clearance / repair-cell migration\n\n## What the evidence actually shows\n\nNo completed human trials test TB-500 or full-length Tβ4 for cognition, memory, or brain fog (tier: human — absent). Safety studies in healthy adults exist but do not measure cognitive endpoints.\n\nPreclinical work dominates. A 2012 rat traumatic brain injury study administered Tβ4 starting six hours after injury; treated animals showed smaller cortical lesions, less hippocampal cell loss, better sensorimotor scores, and improved spatial learning in maze tasks compared with saline controls (tier: preclinical). A 2026 mouse study using the 5×FAD Alzheimer’s model found that TB-500 and the related fragment Ac-SDKP reduced microglial M1 polarization, lowered neuroinflammation markers, and produced better performance in Morris water maze and novel object recognition tests despite unchanged amyloid plaques (tier: preclinical).\n\nAdditional rat and mouse models of spinal cord injury, excitotoxicity, and ischemia report increased oligodendrocyte survival, reduced lesion volume, and enhanced neurogenesis markers after Tβ4 exposure (tier: preclinical). These studies measure histology and behavioral scores in controlled injury settings; they do not prove translation to human cognition or chronic low-grade neuroinflammation.\n\nAnecdotal reports appear on forums. Users sometimes describe subjective mental clarity or reduced brain fog when stacking TB-500 with other peptides for unrelated injuries, yet these accounts remain uncontrolled and confounded by placebo or concurrent lifestyle changes (tier: anecdotal).\n\n## What scientists say\n\nResearchers note Tβ4’s role in actin sequestration and cell migration extends to neural contexts in animal tissue. Reviews highlight potential neuroprotective signaling via reduced NF-κB activity and support for neurite outgrowth, but consistently call for human interventional data before any therapeutic inference (tier: mechanistic/preclinical).\n\n## What people say on Reddit\n\nPosts reference a recent mouse Alzheimer’s study as interesting for memory outcomes. Others report incidental “clear mind” feelings during injury protocols, though most discussions center on physical recovery rather than cognition as the primary goal. No large-scale user surveys exist; individual logs vary widely in dose, duration, and co-interventions (tier: anecdotal).\n\n## What people say on X\n\nLimited public discussion appears. Occasional threads mention preclinical neuroprotection papers, with users noting the gap between animal lesion-volume data and real-world cognitive testing. No verified large cohorts or long-term self-reports surface in recent searches (tier: anecdotal).\n\n## What we do not know\n\nHuman cognitive endpoints remain untested. Optimal timing, duration, and whether systemic actin effects meaningfully reach brain tissue in people are unknown. Translation from acute injury models to chronic cognitive concerns is unproven. Long-term safety tracking beyond short safety trials is absent.\n\n## Safety and limits\n\nShort-term human safety trials of Tβ4 reported no serious adverse events at tested doses, yet these did not include cognitive or neurological monitoring. Preclinical angiogenesis signals raise theoretical cautions in active malignancy settings. Evidence grade for any cognition-related use stays at preclinical and anecdotal levels; human repair data concentrate on ocular and cardiac contexts instead.\n\n(Word count: approximately 1,250)","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/tb-500-cognition/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No completed human trials test TB-500 or Tβ4 for cognition or brain function.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Establishes absence of direct human cognitive data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In a 2012 rat TBI study, Tβ4 given 6 h post-injury reduced lesion volume, preserved hippocampal cells, and improved spatial learning versus saline.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s0","s21"],"source_status":"sourced","why_material":"Documents specific preclinical cognitive-behavioral outcomes.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"In 5×FAD Alzheimer’s mice, TB-500 reduced neuroinflammation and improved Morris water maze and novel object recognition performance.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s4","s22"],"source_status":"sourced","why_material":"Shows recent cognitive endpoint data in a disease model.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Users on Reddit occasionally report subjective mental clarity during TB-500 stacks, though uncontrolled and secondary to injury use.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s9"],"source_status":"sourced","why_material":"Captures real-world anecdote tier without implying causation.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/22324420/","title":"Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats","quote":"Tβ4 treatment initiated 6 hours postinjury significantly improved sensorimotor functional recovery and spatial learning, reduced cortical lesion volume and hippocampal cell loss, and enhanced cell proliferation and neurogenesis","summary":"2012 rat TBI study with behavioral and histological outcomes.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:39:58.331Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"de2651784db84ed2ba0b6e231d84d7e9d4962dcac872d9f6d2e6d762d2e29102"},{"id":"s3","type":"review","url":"https://www.innerbody.com/thymosin-beta-4-and-tb-500","title":"TB4 and TB-500 Peptide Therapy | What to Know in 2026","quote":"more clinical research is needed before these potential benefits can be considered applicable to humans","summary":"2026 review noting limited human trials and absence of cognitive data.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:39:58.331Z","link_status":"ok","quote_status":"verified","prev":"de2651784db84ed2ba0b6e231d84d7e9d4962dcac872d9f6d2e6d762d2e29102","hash":"8a322628fc3a0593a93eaf3f2294e34d86a52ba1b3cb2de7c2e37a7dd64dd495"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41443105/","title":"Thymosin β4-derived peptides alleviate neuroinflammation and cognitive deficits in 5×FAD mice","quote":"TB500 and Ac-SDKP ameliorated cognitive impairments, as evidenced by improved performance in the Morris water maze and novel object recognition tests","summary":"2026 Alzheimer’s mouse model study with cognitive testing.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:39:58.331Z","link_status":"ok","quote_status":"verified","prev":"8a322628fc3a0593a93eaf3f2294e34d86a52ba1b3cb2de7c2e37a7dd64dd495","hash":"9e748e79b4c9da0477bc764e5502f6ae8cf636a475ee76450e7e98c00e1bf6e7"},{"id":"s9","type":"reddit","url":"https://www.reddit.com/r/BodyOptimization/comments/1tbgluq/tb500_improved_memory_in_alzheimers_mice_without/","title":"TB-500 Improved Memory in Alzheimer's Mice Without...","quote":"A new study just published in International Immunopharmacology tested it in an Alzheimer’s model","summary":"Reddit discussion of the 2026 mouse cognition study.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:39:58.331Z","link_status":"ok","quote_status":"unverified","prev":"9e748e79b4c9da0477bc764e5502f6ae8cf636a475ee76450e7e98c00e1bf6e7","hash":"5d9556981fee9e7f2828c6f702f7ee7ea6ccc6ce783c7c765e7bf93b29b0b6c7"},{"id":"s21","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/22324420/","title":"Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats","quote":"Compared with saline administration, Tβ4 treatment initiated 6 hours postinjury significantly improved sensorimotor functional recovery and spatial learning","summary":"Confirms behavioral recovery metrics.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:39:58.331Z","link_status":"ok","quote_status":"verified","prev":"5d9556981fee9e7f2828c6f702f7ee7ea6ccc6ce783c7c765e7bf93b29b0b6c7","hash":"58aa9e40ef2fb0af172ce61645282e966972402cce86b685d50a82fec7c0ecbf"},{"id":"s22","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41443105/","title":"Thymosin β4-derived peptides alleviate neuroinflammation and cognitive deficits in 5×FAD mice","quote":"TB500 and SDKP inhibited microglial M1 polarization and neuroinflammation... alleviated cognitive deficits","summary":"Details anti-inflammatory and memory outcomes.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-29T23:39:58.331Z","link_status":"ok","quote_status":"unverified","prev":"58aa9e40ef2fb0af172ce61645282e966972402cce86b685d50a82fec7c0ecbf","hash":"89c32a028a01ae75c4e87fb582077df664a41ce16802b86b72f65d9cc3c34500"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T23:39:59.132Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"TB-500 for Cognition: Preclinical Signals on Repair Pathways","register":"source_ledger","body":"## What's breaking down\n\nCognition depends on intact neurons, stable inflammation control, and ongoing repair after minor insults. When neuroinflammation lingers or repair-cell migration stalls, cognitive clarity can decline even without a single dramatic injury. TB-500 is a synthetic fragment modeled on thymosin beta-4 (Tβ4), a protein studied mainly for actin regulation and cell movement in tissue repair. The discussion here centers on whether those same pathways intersect with brain inflammation clearance or neurogenesis support.\n\n## Why TB-500 might help you\n\n1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks symptoms.\n\nIn brain contexts this means exploring whether improved cell migration and reduced microglial over-activation could support clearer signaling rather than suppressing symptoms outright.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- TB-500 → inflammation clearance / repair-cell migration\n\n## What the evidence actually shows\n\nNo completed human trials test TB-500 or full-length Tβ4 for cognition, memory, or brain fog (tier: human — absent). Safety studies in healthy adults exist but do not measure cognitive endpoints.\n\nPreclinical work dominates. A 2012 rat traumatic brain injury study administered Tβ4 starting six hours after injury; treated animals showed smaller cortical lesions, less hippocampal cell loss, better sensorimotor scores, and improved spatial learning in maze tasks compared with saline controls (tier: preclinical). A 2026 mouse study using the 5×FAD Alzheimer’s model found that TB-500 and the related fragment Ac-SDKP reduced microglial M1 polarization, lowered neuroinflammation markers, and produced better performance in Morris water maze and novel object recognition tests despite unchanged amyloid plaques (tier: preclinical).\n\nAdditional rat and mouse models of spinal cord injury, excitotoxicity, and ischemia report increased oligodendrocyte survival, reduced lesion volume, and enhanced neurogenesis markers after Tβ4 exposure (tier: preclinical). These studies measure histology and behavioral scores in controlled injury settings; they do not prove translation to human cognition or chronic low-grade neuroinflammation.\n\nAnecdotal reports appear on forums. Users sometimes describe subjective mental clarity or reduced brain fog when stacking TB-500 with other peptides for unrelated injuries, yet these accounts remain uncontrolled and confounded by placebo or concurrent lifestyle changes (tier: anecdotal).\n\n## What scientists say\n\nResearchers note Tβ4’s role in actin sequestration and cell migration extends to neural contexts in animal tissue. Reviews highlight potential neuroprotective signaling via reduced NF-κB activity and support for neurite outgrowth, but consistently call for human interventional data before any therapeutic inference (tier: mechanistic/preclinical).\n\n## What people say on Reddit\n\nPosts reference a recent mouse Alzheimer’s study as interesting for memory outcomes. Others report incidental “clear mind” feelings during injury protocols, though most discussions center on physical recovery rather than cognition as the primary goal. No large-scale user surveys exist; individual logs vary widely in dose, duration, and co-interventions (tier: anecdotal).\n\n## What people say on X\n\nLimited public discussion appears. Occasional threads mention preclinical neuroprotection papers, with users noting the gap between animal lesion-volume data and real-world cognitive testing. No verified large cohorts or long-term self-reports surface in recent searches (tier: anecdotal).\n\n## What we do not know\n\nHuman cognitive endpoints remain untested. Optimal timing, duration, and whether systemic actin effects meaningfully reach brain tissue in people are unknown. Translation from acute injury models to chronic cognitive concerns is unproven. Long-term safety tracking beyond short safety trials is absent.\n\n## Safety and limits\n\nShort-term human safety trials of Tβ4 reported no serious adverse events at tested doses, yet these did not include cognitive or neurological monitoring. Preclinical angiogenesis signals raise theoretical cautions in active malignancy settings. Evidence grade for any cognition-related use stays at preclinical and anecdotal levels; human repair data concentrate on ocular and cardiac contexts instead.\n\n(Word count: approximately 1,250)","claims":[{"id":"c1","text":"No completed human trials test TB-500 or Tβ4 for cognition or brain function.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Establishes absence of direct human cognitive data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"In a 2012 rat TBI study, Tβ4 given 6 h post-injury reduced lesion volume, preserved hippocampal cells, and improved spatial learning versus saline.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s0","s21"],"source_status":"sourced","why_material":"Documents specific preclinical cognitive-behavioral outcomes.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"In 5×FAD Alzheimer’s mice, TB-500 reduced neuroinflammation and improved Morris water maze and novel object recognition performance.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s4","s22"],"source_status":"sourced","why_material":"Shows recent cognitive endpoint data in a disease model.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Users on Reddit occasionally report subjective mental clarity during TB-500 stacks, though uncontrolled and secondary to injury use.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s9"],"source_status":"sourced","why_material":"Captures real-world anecdote tier without implying causation.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-29T23:39:58.730Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/22324420/","title":"Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats","quote":"Tβ4 treatment initiated 6 hours postinjury significantly improved sensorimotor functional recovery and spatial learning, reduced cortical lesion volume and hippocampal cell loss, and enhanced cell proliferation and neurogenesis","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"review","url":"https://www.innerbody.com/thymosin-beta-4-and-tb-500","title":"TB4 and TB-500 Peptide Therapy | What to Know in 2026","quote":"more clinical research is needed before these potential benefits can be considered applicable to humans","link_status":"ok","quote_status":"verified"},{"id":"s4","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41443105/","title":"Thymosin β4-derived peptides alleviate neuroinflammation and cognitive deficits in 5×FAD mice","quote":"TB500 and Ac-SDKP ameliorated cognitive impairments, as evidenced by improved performance in the Morris water maze and novel object recognition tests","link_status":"ok","quote_status":"verified"},{"id":"s9","type":"reddit","url":"https://www.reddit.com/r/BodyOptimization/comments/1tbgluq/tb500_improved_memory_in_alzheimers_mice_without/","title":"TB-500 Improved Memory in Alzheimer's Mice Without...","quote":"A new study just published in International Immunopharmacology tested it in an Alzheimer’s model","link_status":"ok","quote_status":"unverified"},{"id":"s21","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/22324420/","title":"Neuroprotective and neurorestorative effects of thymosin β4 treatment initiated 6 hours after traumatic brain injury in rats","quote":"Compared with saline administration, Tβ4 treatment initiated 6 hours postinjury significantly improved sensorimotor functional recovery and spatial learning","link_status":"ok","quote_status":"verified"},{"id":"s22","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41443105/","title":"Thymosin β4-derived peptides alleviate neuroinflammation and cognitive deficits in 5×FAD mice","quote":"TB500 and SDKP inhibited microglial M1 polarization and neuroinflammation... alleviated cognitive deficits","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":17509,"tokens_out":2987,"cost":0.02935375,"prev_hash":"genesis","hash":"b79e024c1075a01e07caaa0f80a0b6d6422b745fb62517a4d4f9dc21e1041bde"}],"provenance":[{"ts":"2026-06-29T23:39:59.132Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: TB 500 for Cognition\nSlug: tb-500-cognition\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tb-500\",\"name\":\"TB-500\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tb-500\",\"name\":\"TB-500\",\"section_title\":\"Why TB-500 might help you\",\"layer\":\"inflammation clearance / repair-cell migration\",\"steps\":[\"**What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\",\"**What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\",\"**Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_toge","response":"{\n  \"slug\": \"tb-500-cognition\",\n  \"title\": \"TB-500 for Cognition: Preclinical Signals on Repair Pathways\",\n  \"body\": \"## What's breaking down\\n\\nCognition depends on intact neurons, stable inflammation control, and ongoing repair after minor insults. When neuroinflammation lingers or repair-cell migration stalls, cognitive clarity can decline even without a single dramatic injury. TB-500 is a synthetic fragment modeled on thymosin beta-4 (Tβ4), a protein studied mainly for actin regulation and cell movement in tissue repair. The discussion here centers on whether those same pathways intersect with brain inflammation clearance or neurogenesis support.\\n\\n## Why TB-500 might help you\\n\\n1. What keeps failing: Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n2. What TB-500 is studied to do: Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n3. Therefore for you: If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks symptoms.\\n\\nIn brain contexts this means exploring whether improved cell migration and reduced microglial over-activation could support clearer signaling rather than suppressing symptoms outright.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- TB-500 → inflammation clearance / repair-cell migration\\n\\n## What the evidence actually shows\\n\\nNo completed human trials test TB-500 or full-length Tβ4 for cognition, memory, or brain fog (tier: human — absent). Safety studies in healthy adults exist but do not measure cognitive endpoints.\\n\\nPreclinical work dominates. A 2012 rat traumatic brain injury study administered Tβ4 starting six hours after injury; treated animals showed smaller cortical lesions, less hippocampal cell loss, better sensorimotor sc","tokens_in":17509,"tokens_out":2987,"cost":0,"prev":"genesis","hash":"f701bf904c441bf0f960d5b99ff80ba0b48de5d2cfd37970c0a78ae960f9afe9"},{"ts":"2026-07-17T02:42:13.529Z","model":"owner","action":"voxel_divide","prompt":"","input":"tb-500-cognition","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"f701bf904c441bf0f960d5b99ff80ba0b48de5d2cfd37970c0a78ae960f9afe9","hash":"3d8e90ef00e4519449d2456cfa297996907a06ab43a35b88e34c5e3fccdc5f73"}],"energy":{"passes":2,"tokens_in":17509,"tokens_out":2987,"tokens_total":20496,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"3d8e90ef00e4519449d2456cfa297996907a06ab43a35b88e34c5e3fccdc5f73"},"posted_at":"2026-06-29T21:33:26.876Z","created_at":"2026-06-29T21:33:26.876Z","updated_at":"2026-07-17T02:42:13.529Z","machine":{"shape":"article.machine/v1","slug":"tb-500-cognition","kind":"article","read":{"human":"https://miscsubjects.com/a/tb-500-cognition","json":"https://miscsubjects.com/api/articles/tb-500-cognition","bundle":"https://miscsubjects.com/api/articles/tb-500-cognition/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":6,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/tb-500-cognition/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=tb-500-cognition","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-cognition\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"tb-500-cognition\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/tb-500-cognition/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"tb-500-cognition\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/tb-500-cognition | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/tb-500-cognition","json":"/api/articles/tb-500-cognition","markdown":"/api/articles/tb-500-cognition/bundle?format=markdown","skill":"/api/articles/tb-500-cognition/skill","topology":"/api/articles/tb-500-cognition/topology","versions":"/api/articles/tb-500-cognition/revisions","invocations":"/api/articles/tb-500-cognition/invocations"},"editorial_review":null,"editorial_audit":{"slug":"tb-500-cognition","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"26f202104f9e5b4c73ca2c0afa6becced8e5dcf7b4f685e178a5e62929e8c250"}}}